The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease.
<h4>Background</h4>Recent evidence suggests a crucial role of the endocannabinoid system, including the cannabinoid 1 receptor (CNR1), in intestinal inflammation. We therefore investigated the influence of the CNR1 1359 G/A (p.Thr453Thr; rs1049353) single nucleotide polymorphism (SNP) on...
Saved in:
Main Authors: | Martin Storr, Dominik Emmerdinger, Julia Diegelmann, Simone Pfennig, Thomas Ochsenkühn, Burkhard Göke, Peter Lohse, Stephan Brand |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2010
|
Subjects: | |
Online Access: | https://doaj.org/article/da13048bf34d4a2d8f8e486e7f896ad6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acta N°1359
by: Banco Central de Chile
Published: (2021) -
Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2.
by: Julia Diegelmann, et al.
Published: (2013) -
Selected Morphotic Parameters Differentiating Ulcerative Colitis from Crohn’s Disease
by: Kasperczuk Anna
Published: (2021) -
Selective biologics for ulcerative colitis and Crohn's disease – clinical utility of vedolizumab
by: Petkau JM, et al.
Published: (2016) -
Systems biology approach highlights mechanistic differences between Crohn’s disease and ulcerative colitis
by: Pedro A. Ruiz Castro, et al.
Published: (2021)